Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues

Bhavesh D. Kevadiya, Brendan Ottemann, Insiya Z. Mukadam, Laura Castellanos, Kristen Sikora, James R. Hilaire, Jatin Machhi, Jonathan Herskovitz, Dhruvkumar Soni, Mahmudul Hasan, Wenting Zhang, Sarella Anandakumar, Jered Garrison, Jo Ellyn McMillan, Benson Edagwa, R. Lee Mosley, Richard W. Vachet, Howard E. Gendelman

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus theranostics facilitates the development of long acting (LA) antiretroviral drugs (ARVs) by defining drug-particle cell depots. Optimal drug formulations are made possible based on precise particle composition, structure, shape and size. Through the creation of rod-shaped particles of defined sizes reflective of native LA drugs, theranostic probes can be deployed to measure particle-cell and tissue biodistribution, antiretroviral activities and drug retention. Methods: Herein, we created multimodal rilpivirine (RPV) 177lutetium labeled bismuth sulfide nanorods (177LuBSNRs) then evaluated their structure, morphology, configuration, chemical composition, biological responses and adverse reactions. Particle biodistribution was analyzed by single photon emission computed tomography (SPECT/CT) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging. Results: Nanoformulated RPV and BSNRs-RPV particles showed comparable physicochemical and cell biological properties. Drug-particle pharmacokinetics (PK) and biodistribution in lymphoid tissue macrophages proved equivalent, one with the other. Rapid particle uptake and tissue distribution were observed, without adverse reactions, in primary blood-derived and tissue macrophages. The latter was seen within the marginal zones of spleen. Conclusions: These data, taken together, support the use of 177LuBSNRs as theranostic probes as a rapid assessment tool for PK LA ARV measurements.

Original languageEnglish (US)
Pages (from-to)630-656
Number of pages27
JournalTheranostics
Volume10
Issue number2
DOIs
StatePublished - Jan 1 2020

Fingerprint

Rilpivirine
Nanoparticles
HIV
Nanotubes
Pharmaceutical Preparations
Pharmacokinetics
Macrophages
Drug Compounding
Laser Therapy
Lymphoid Tissue
Tissue Distribution
Single-Photon Emission-Computed Tomography
Particle Size
Mass Spectrometry
Spleen
Theranostic Nanomedicine

Keywords

  • Drug biodistribution
  • Laser ablation inductively coupled plasma mass spectrometry
  • Long acting antiretroviral therapy
  • Multimodal imaging
  • Single photon emission computed tomography

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues. / Kevadiya, Bhavesh D.; Ottemann, Brendan; Mukadam, Insiya Z.; Castellanos, Laura; Sikora, Kristen; Hilaire, James R.; Machhi, Jatin; Herskovitz, Jonathan; Soni, Dhruvkumar; Hasan, Mahmudul; Zhang, Wenting; Anandakumar, Sarella; Garrison, Jered; McMillan, Jo Ellyn; Edagwa, Benson; Mosley, R. Lee; Vachet, Richard W.; Gendelman, Howard E.

In: Theranostics, Vol. 10, No. 2, 01.01.2020, p. 630-656.

Research output: Contribution to journalArticle

Kevadiya, BD, Ottemann, B, Mukadam, IZ, Castellanos, L, Sikora, K, Hilaire, JR, Machhi, J, Herskovitz, J, Soni, D, Hasan, M, Zhang, W, Anandakumar, S, Garrison, J, McMillan, JE, Edagwa, B, Mosley, RL, Vachet, RW & Gendelman, HE 2020, 'Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues', Theranostics, vol. 10, no. 2, pp. 630-656. https://doi.org/10.7150/thno.39847
Kevadiya, Bhavesh D. ; Ottemann, Brendan ; Mukadam, Insiya Z. ; Castellanos, Laura ; Sikora, Kristen ; Hilaire, James R. ; Machhi, Jatin ; Herskovitz, Jonathan ; Soni, Dhruvkumar ; Hasan, Mahmudul ; Zhang, Wenting ; Anandakumar, Sarella ; Garrison, Jered ; McMillan, Jo Ellyn ; Edagwa, Benson ; Mosley, R. Lee ; Vachet, Richard W. ; Gendelman, Howard E. / Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues. In: Theranostics. 2020 ; Vol. 10, No. 2. pp. 630-656.
@article{b5c12c5e48b24049a3409f2ee07aaed0,
title = "Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues",
abstract = "Human immunodeficiency virus theranostics facilitates the development of long acting (LA) antiretroviral drugs (ARVs) by defining drug-particle cell depots. Optimal drug formulations are made possible based on precise particle composition, structure, shape and size. Through the creation of rod-shaped particles of defined sizes reflective of native LA drugs, theranostic probes can be deployed to measure particle-cell and tissue biodistribution, antiretroviral activities and drug retention. Methods: Herein, we created multimodal rilpivirine (RPV) 177lutetium labeled bismuth sulfide nanorods (177LuBSNRs) then evaluated their structure, morphology, configuration, chemical composition, biological responses and adverse reactions. Particle biodistribution was analyzed by single photon emission computed tomography (SPECT/CT) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging. Results: Nanoformulated RPV and BSNRs-RPV particles showed comparable physicochemical and cell biological properties. Drug-particle pharmacokinetics (PK) and biodistribution in lymphoid tissue macrophages proved equivalent, one with the other. Rapid particle uptake and tissue distribution were observed, without adverse reactions, in primary blood-derived and tissue macrophages. The latter was seen within the marginal zones of spleen. Conclusions: These data, taken together, support the use of 177LuBSNRs as theranostic probes as a rapid assessment tool for PK LA ARV measurements.",
keywords = "Drug biodistribution, Laser ablation inductively coupled plasma mass spectrometry, Long acting antiretroviral therapy, Multimodal imaging, Single photon emission computed tomography",
author = "Kevadiya, {Bhavesh D.} and Brendan Ottemann and Mukadam, {Insiya Z.} and Laura Castellanos and Kristen Sikora and Hilaire, {James R.} and Jatin Machhi and Jonathan Herskovitz and Dhruvkumar Soni and Mahmudul Hasan and Wenting Zhang and Sarella Anandakumar and Jered Garrison and McMillan, {Jo Ellyn} and Benson Edagwa and Mosley, {R. Lee} and Vachet, {Richard W.} and Gendelman, {Howard E.}",
year = "2020",
month = "1",
day = "1",
doi = "10.7150/thno.39847",
language = "English (US)",
volume = "10",
pages = "630--656",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "2",

}

TY - JOUR

T1 - Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues

AU - Kevadiya, Bhavesh D.

AU - Ottemann, Brendan

AU - Mukadam, Insiya Z.

AU - Castellanos, Laura

AU - Sikora, Kristen

AU - Hilaire, James R.

AU - Machhi, Jatin

AU - Herskovitz, Jonathan

AU - Soni, Dhruvkumar

AU - Hasan, Mahmudul

AU - Zhang, Wenting

AU - Anandakumar, Sarella

AU - Garrison, Jered

AU - McMillan, Jo Ellyn

AU - Edagwa, Benson

AU - Mosley, R. Lee

AU - Vachet, Richard W.

AU - Gendelman, Howard E.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Human immunodeficiency virus theranostics facilitates the development of long acting (LA) antiretroviral drugs (ARVs) by defining drug-particle cell depots. Optimal drug formulations are made possible based on precise particle composition, structure, shape and size. Through the creation of rod-shaped particles of defined sizes reflective of native LA drugs, theranostic probes can be deployed to measure particle-cell and tissue biodistribution, antiretroviral activities and drug retention. Methods: Herein, we created multimodal rilpivirine (RPV) 177lutetium labeled bismuth sulfide nanorods (177LuBSNRs) then evaluated their structure, morphology, configuration, chemical composition, biological responses and adverse reactions. Particle biodistribution was analyzed by single photon emission computed tomography (SPECT/CT) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging. Results: Nanoformulated RPV and BSNRs-RPV particles showed comparable physicochemical and cell biological properties. Drug-particle pharmacokinetics (PK) and biodistribution in lymphoid tissue macrophages proved equivalent, one with the other. Rapid particle uptake and tissue distribution were observed, without adverse reactions, in primary blood-derived and tissue macrophages. The latter was seen within the marginal zones of spleen. Conclusions: These data, taken together, support the use of 177LuBSNRs as theranostic probes as a rapid assessment tool for PK LA ARV measurements.

AB - Human immunodeficiency virus theranostics facilitates the development of long acting (LA) antiretroviral drugs (ARVs) by defining drug-particle cell depots. Optimal drug formulations are made possible based on precise particle composition, structure, shape and size. Through the creation of rod-shaped particles of defined sizes reflective of native LA drugs, theranostic probes can be deployed to measure particle-cell and tissue biodistribution, antiretroviral activities and drug retention. Methods: Herein, we created multimodal rilpivirine (RPV) 177lutetium labeled bismuth sulfide nanorods (177LuBSNRs) then evaluated their structure, morphology, configuration, chemical composition, biological responses and adverse reactions. Particle biodistribution was analyzed by single photon emission computed tomography (SPECT/CT) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging. Results: Nanoformulated RPV and BSNRs-RPV particles showed comparable physicochemical and cell biological properties. Drug-particle pharmacokinetics (PK) and biodistribution in lymphoid tissue macrophages proved equivalent, one with the other. Rapid particle uptake and tissue distribution were observed, without adverse reactions, in primary blood-derived and tissue macrophages. The latter was seen within the marginal zones of spleen. Conclusions: These data, taken together, support the use of 177LuBSNRs as theranostic probes as a rapid assessment tool for PK LA ARV measurements.

KW - Drug biodistribution

KW - Laser ablation inductively coupled plasma mass spectrometry

KW - Long acting antiretroviral therapy

KW - Multimodal imaging

KW - Single photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=85076574661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076574661&partnerID=8YFLogxK

U2 - 10.7150/thno.39847

DO - 10.7150/thno.39847

M3 - Article

C2 - 31903142

AN - SCOPUS:85076574661

VL - 10

SP - 630

EP - 656

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 2

ER -